Sign In
Buy RGC
$5.28
-0.130 (-2.40%)
At Close: Aug 10, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regencell To Contact Him Directly To Discuss Their Options If you purchased or acquir
RGC LAWSUIT ALERT: Levi & Korsinsky Notifies Regencell Bioscience Holdings Limited Investors of a Class Action Lawsuit and Upcoming Deadline
09:00am, Wednesday, 29'th Apr 2026
NEW YORK, April 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Regencell Bioscience Holdings Limited ("Regencell Bioscience Holdings Limited" or the "Company") (NASDAQ: RGC) of
New York, New York--(Newsfile Corp. - April 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Regencell Bios
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
04:09pm, Tuesday, 28'th Apr 2026
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NA
RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit with the Schall Law Firm
10:16pm, Monday, 27'th Apr 2026
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regencell Bioscience Holdings Li
RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit with the Schall Law Firm
10:16pm, Monday, 27'th Apr 2026
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regencell Bioscience Holdings L
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Regencell Bioscience Hold
Bragar Eagel and Squire, P. C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Regencell (RGC) To Contact Him Directly To Discuss Their Options If you purchased or acquir
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Regencell (RGC) To Contact Him Directly To Discuss Their Options
RGC Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Regencell Bioscience Holdings Limited
09:15pm, Monday, 27'th Apr 2026
SAN DIEGO, April 27, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings L
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Regencell Bioscience Holdings Limited (NASDAQ: R
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited (RGC)
03:28pm, Monday, 27'th Apr 2026
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Maryland
New class action for Regencell (RGC) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 6/23/2026
Portnoy Law Firm Announces Class Action on Behalf of Regencell Bioscience Holdings Limited Investors
11:36am, Monday, 27'th Apr 2026
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regencell Bioscience Holdings Limited, ("Regencell" or the "Company") (NASDAQ: RGC) investors of a class action on behalf o
Portnoy Law Firm Announces Class Action on Behalf of Regencell Bioscience Holdings Limited Investors
11:36am, Monday, 27'th Apr 2026
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regencell Bioscience Holdings Limited, (“Regencell” or the "Company") (NASDAQ: RGC) investors of a class action on beh
